Literature DB >> 10321877

Dural arteriovenous malformation manifesting as dementia due to ischemia in bilateral thalami. A case report.

K Tanaka1, Y Morooka, Y Nakagawa, S Shimizu.   

Abstract

BACKGROUND: Although dementia is one of the curable manifestations of a dural arteriovenous malformation (AVM), the pathophysiology remains unclear. CASE DESCRIPTION: We describe an elderly patient who had an AVM in the tentorium and manifested signs of dementia from ischemia, predominantly in the bilateral thalami. Intravascular embolization of the dural AVM resulted in amelioration of signs of dementia, and this improvement was consistent with that of neuroradiological and hemodynamic conditions in the thalami.
CONCLUSION: The coincidental improvement of CBF in the thalami and signs of dementia after embolization of the AV shunt supports the concept of primary participation of the thalami in the pathophysiology of dementia of vascular origin in our patient.

Entities:  

Mesh:

Year:  1999        PMID: 10321877     DOI: 10.1016/s0090-3019(98)00020-2

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  4 in total

1.  Dural arteriovenous fistula (D-AVF): a rare cause of symmetrical bithalamic changes with free diffusivity changes.

Authors:  Pervinder Bhogal; Oliver Duxbury; Prem Rangi
Journal:  BMJ Case Rep       Date:  2014-10-29

2.  Dural arteriovenous fistula presenting as thalamic dementia: a case description with rare imaging findings.

Authors:  Renjie Liu; Yuhao Zhao; Haoyuan Yin; Zhongqiang Shi; Xuan Chen
Journal:  Quant Imaging Med Surg       Date:  2022-05

3.  Progressive Neurological Decline with Deep Bilateral Imaging Changes: A Protean Presentation of Dural Arteriovenous Fistulae.

Authors:  Rene A Colorado; Marcelo Matiello; Hyun-Sik Yang; James D Rabinov; Aman Patel; Joshua A Hirsch; Ram Chavali; Thabele M Leslie-Mazwi
Journal:  Interv Neurol       Date:  2018-03-27

Review 4.  Neuropsychological effects of brain arteriovenous malformations.

Authors:  Emily R Lantz; Philip M Meyers
Journal:  Neuropsychol Rev       Date:  2008-05-24       Impact factor: 7.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.